| Dr Richard A Chole, MD | |
|
1 Childrens Pl Ste 3s, Ste 3s, Saint Louis, MO 63110-1002 | |
| (314) 454-6162 | |
| (314) 454-2174 |
| Full Name | Dr Richard A Chole |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology - Otology & Neurotology |
| Location | 1 Childrens Pl Ste 3s, Saint Louis, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043236276 | NPI | - | NPPES |
| 209750603 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0901X | Otolaryngology - Otology & Neurotology | 114392 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard A Chole, MD 660 S Euclid Ave, C B 8115, Saint Louis, MO 63110-1010 Ph: (314) 362-7509 | Dr Richard A Chole, MD 1 Childrens Pl Ste 3s, Ste 3s, Saint Louis, MO 63110-1002 Ph: (314) 454-6162 |
News Archive
"When it comes to promoting global health, the American people have much to celebrate and be proud of. With strong bipartisan support, the U.S. government has not only committed many billions of dollars and saved many millions of lives, it has changed the way the world approaches foreign aid," former U.S. Global AIDS Coordinator Ambassador Mark Dybul writes in an opinion piece in The Hill.
Scientists from the National Institute of Allergy and Infectious Diseases, the National Institute of Dental and Craniofacial Research, and the National Heart, Lung and Blood Institute all parts of the National Institutes of Health, describe how combining engineered anthrax toxin proteins and existing chemotherapy drugs could potentially yield a therapy to reduce or eliminate cancerous tumors.
Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.
Increased risk of fracture has been shown to be one of the complications arising from longstanding diabetes. With the worldwide increase in Type 2 Diabetes (T2D), in part due to aging populations, there is also increasing concern about how to identify and manage patients with diabetes who are at high risk of osteoporotic fracture.
Novo Nordisk today announced the availability of HemaGo™ XChange, a web-based portal that allows people with hemophilia to connect their circle of care to their treatment and bleed information, promoting collaboration and discussion regarding the management of their bleeding disorder.
› Verified 7 days ago
Mark F Stroble, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 12399 Gravois Rd, Ste 120, Saint Louis, MO 63127 Phone: 314-843-3828 Fax: 314-843-3052 | |
Arya W Namin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 607 S New Ballas Rd Ste 2300, Saint Louis, MO 63141 Phone: 314-251-6394 Fax: 314-251-4235 | |
Dr. Ethan Craig, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-5000 | |
Dr. Timothy J Reichert, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 621 S New Ballas Rd, Suite 622a, Saint Louis, MO 63141 Phone: 314-872-8340 Fax: 314-872-8399 | |
Dr. Cameron Connelly Wick, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4921 Parkview Pl, Dept Otolaryngology, Ste 11a, Saint Louis, MO 63110 Phone: 314-362-7509 Fax: 314-362-7522 | |
Dr. Matthew Lee Rohlfing, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4921 Parkview Pl, Dept Otolaryngology, Ste 11a, Saint Louis, MO 63110 Phone: 314-362-7509 Fax: 314-362-7522 |